BBK Holdings opens European subsidiary to support clinical trials

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Oleski Liskonih)
(Image: Getty/Oleski Liskonih)

Related tags: Clinical trials, Clinical data, Patient centricity, Clinical trial, Patient recruitment, GDPR, Brexit

BBK Holdings, parent company of BBK Worldwide, has established BBK Patient Experience Limited to support patient data protection in clinical trials and add to its footprint in the EU.

BBK Holdings parent company of BBK Worldwide announced the building of additional subsidiary in the EU BBK Patient Experience Limited located in Dublin, Ireland to support the company’s reimbursement programs to increase access to care while supporting data protection initiatives.

Joan Bachenheimer, founding principal and CEO of BBK Worldwide told us that establishing this subsidiary in the EU served a twofold purpose. It will facilitate requirements for international banking organizations, and support data protection mandated by the European Union’s General Data Protection Regulation (GDPR​).

“This was the most logical move in order to not only be able to respond quickly to the shifting global landscape but to ensure we provide patients with the services they need for a positive clinical trial experience,”​ Bachenheimer added.

GDPR applies not only to EU organizations but also located outside of Europe that provides goods or services to citizens in the region.

BBK’s technology-based reimbursement and travel programs, RSG Card and RSG Arrive, were launched in 2013. Bachenheimer told us that reimbursement​ is important in clinical trials as it removes barriers to patient participation and removes administrative tasks from the site. The company released a report stated that 40% of patients said travel assistance would have been helpful in the clinical trial experience.

Related news

Show more

Related products

show more

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars